Catalent Appoints First President of Asia Pacific Group - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Catalent Appoints First President of Asia Pacific Group



Catalent has named David Heyens in the new role of president of Catalent Asia Pacific. Reporting directly to Catalent’s president and CEO, John Chiminski, Heyens was hired to drive Catalent’s growth in the region following the company’s recent expansion into China, and build on Catalent’s regional operations in Japan, Australia, and Singapore.

Replacing Heyens as the president of Catalent Softgel Technologies will be Aris Gennadios, PhD. Also reporting to Chiminski, Gennadios will have full strategic responsibility for the soft gel development, delivery, and supply business with 10 global manufacturing facilities that deliver pharmaceutical, generic, and consumer health soft gel products to markets worldwide.

Source: Catalent

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here